Insilico lands heavily backloaded $2.5B AI drug discovery deal with SK Biopharm on June 22, 2026 AI drug discovery CNS disorder Infrequent Insilico Medicine milestone payments nervous system disorder neurodegenerative neuroimmune disorders neuroinflammatory Pharma SK Biopharmaceuticals upfront payment +
Microsoft and INBRAIN Collaborate to Explore Agentic AI for Next-Generation Brain Therapies on November 11, 2025 Agentic AI Brain-Computer Interfaces closed-loop interventions INBRAIN Microsoft nervous system disorder next-gen brain therapies precision neurology real-time monitoring +
Ionis Heads to FDA as Antisense Therapy Aces Pivotal Study in Rare Neurological Disease on September 23, 2025 Alexander Disease Antisense Oligonucleotides Fast Track Identifier Infrequent Ionis Pharmaceuticals nervous system disorder Phase I – III study United States Food and Drug Administration Zilganersen +
Merck KGaA and Skyhawk Therapeutics Launch $2B RNA-Targeting Neurology Collaboration on August 22, 2025 Billion Collaboration Drug Development Merck KGaA milestone payments nervous system disorder RNA-targeting royalties Skyhawk SkySTAR platform +